New collaboration between Marie Curie Cancer Care and Cancer Research UK

In collaboration with the Press Association

Marie Curie Cancer Care and Cancer Research UK have announced a new research collaboration to improve the care of people who are nearing the end of their lives.

A new research fund will be launched for end of life care research by Marie Curie Cancer Care, which will invest an additional £1 million a year into the new national programme.

The charity will be assisted by Cancer Research UK, who have extensive expertise in evaluating research applications, grant funding and the peer review process.

At present, less than £20 million is spent on end of life research each year in the UK, out of an overall budget of £400 million that is spent on research into cancer prevention and treatment.

News of the collaboration was announced at the National Cancer Research Institute Conference in Birmingham today (October 5th) by Dr Teresa Tate, medical advisor for Marie Curie Cancer Care.

"Now is the time to deliver a real boost to innovation, improvement and research into better end of life care in the UK," said Dr Tate.

"This is why Marie Curie has made the decision to invest more into palliative care research across the UK, doing our best to address the current under-funding for such crucial work.

"Bringing the expertise of Cancer Research UK on board will ensure all research proposals are thoroughly reviewed and expertly assessed. It's a great example of cooperation between two major charities with different but complementary strengths."

Lilian Clark, executive director of science operations and funding at Cancer Research UK, said that the charity is "delighted" by the collaboration.

"Marie Curie has great expertise and knowledge around end of life care and we look forward to helping them develop a coherent and rigorous research programme in this area of acknowledged under-investment," she said.

"The strengths of both charities will combine to create a unique opportunity to deliver world class research in this field."